Literature DB >> 6148398

New sulfamoylphenethylamines, potent alpha 1-adrenoceptor antagonists.

T Takenaka, K Honda, T Fujikura, K Niigata, S Tachikawa, N Inukai.   

Abstract

The (+)-isomer of amosulalol, a combined alpha- and beta-adrenoceptor antagonist, was one log unit order more potent and less potent than the (-)-isomer in blocking alpha 1- and beta 1-adrenoceptors, respectively, in anaesthetized rats. Nine newly synthesized desoxy compounds derived from amosulalol and its analogues were found to possess potent alpha 1-adrenoceptor blocking activity and to be practically devoid of beta 1-adrenoceptor blocking activity. Among the desoxy derivatives, YM-12617 was more potent than prazosin in blocking alpha 1-adrenoceptors in anaesthetized rats and in reducing blood pressure, total peripheral resistance and left ventricular work in anaesthetized dogs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148398     DOI: 10.1111/j.2042-7158.1984.tb04447.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

1.  Beneficial effect of amosulalol and phentolamine on post-hypoxic recovery of contractile force and energy metabolism in rabbit hearts.

Authors:  K Tanonaka; M Matsumoto; R Minematsu; K Miyake; R Murai; S Takeo
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

2.  The effect of selective 5-hydroxytryptamine uptake inhibitors on 5-methoxy-N,N-dimethyltryptamine-induced ejaculation in the rat.

Authors:  L Rényi
Journal:  Br J Pharmacol       Date:  1986-04       Impact factor: 8.739

3.  Studies on YM-12617: a selective and potent antagonist of postsynaptic alpha 1-adrenoceptors.

Authors:  K Honda; T Takenaka; A Miyata-Osawa; M Terai; K Shiono
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

4.  Further studies on (+/-)-YM-12617, a potent and selective alpha 1-adrenoceptor antagonist and its individual optical enantiomers.

Authors:  K Honda; C Nakagawa; M Terai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.